BRG-1 deficiency has been reported in approximately 2-3% of non-small cell lung cancers (NSCLCs), with a higher prevalence in certain subtypes such as large cell carcinomas and sarcomatoid carcinomas (1). This evidence concerns the gene SMARCA4 and sarcomatoid carcinoma.